Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

6.18CNY
23 Mar 2017
Change (% chg)

¥0.02 (+0.32%)
Prev Close
¥6.16
Open
¥6.15
Day's High
¥6.18
Day's Low
¥6.12
Volume
4,253,937
Avg. Vol
6,681,010
52-wk High
¥7.46
52-wk Low
¥5.98

Latest Key Developments (Source: Significant Developments)

North China Pharmaceutical receives GMP certificate
Wednesday, 22 Mar 2017 05:41am EDT 

North China Pharmaceutical Co Ltd <600812.SS> : Says it received goods manufacture practice(GMP) certificate from Hebei Food and Drug Administration on March 21 . Certificate issued to production line for manufacturing Amoxicillin Dispersible tablets, Amoxicillin and Clavulanate Potassium tablets and Amoxil capsule .Valid until Feb. 23, 2022.  Full Article

North China Pharma's chairman resigns due to personal reasons
Thursday, 9 Feb 2017 05:00am EST 

North China Pharmaceutical Co Ltd <600812.SS> :Says its Chairman Guo Zhouke resigns due to personal reasons.  Full Article

North China Pharmaceutical unit receives GMP certificate
Sunday, 8 Jan 2017 11:33pm EST 

North China Pharmaceutical Co Ltd <600812.SS> : Says its wholly owned pharma unit received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Jan. 6 .Certificate issued to production line for manufacturing ciclosporin and the valid period is until Dec. 12, 2021.  Full Article

North China Pharmaceutical receives GMP certificate
Thursday, 8 Dec 2016 03:47am EST 

North China Pharmaceutical <600812.SS>: Says it received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration on Dec. 5 .Certificate issued to tablets, hard capsules, oral solutions manufactured by the company and the valid period is until Nov. 14, 2021.  Full Article

North China Pharmaceutical gets approval for clinical trial
Wednesday, 26 Oct 2016 04:16am EDT 

North China Pharmaceutical Co Ltd <600812.SS>:Says it received approval from Food and Drug Administration Bureau on Oct. 25 for clinical trial of capecitabine tablets.  Full Article

North China Pharmaceutical says Yang Haijing resigns from chairman
Tuesday, 11 Oct 2016 04:47am EDT 

North China Pharmaceutical <600812.SS>:Says Yang Haijing resigned from chairman of the board on Oct. 10.  Full Article

North China Pharmaceutical unit wins lawsuit
Thursday, 22 Sep 2016 02:04am EDT 

North China Pharmaceutical Co Ltd <600812.SS>:Says its unit received judgment from United States Court of Appeals for the Second Circuit made on Sep. 20 that the court withdrew the original judgment regarding Chinese companies' vitamin C antitrust litigation and rejected the appeal from plaintiff.  Full Article

North China Pharmaceutical unit gets nod for clinic trial
Monday, 22 Aug 2016 09:49pm EDT 

North China Pharmaceutical Co Ltd <600812.SS>:Says its unit gets China Food and Drug Administration's approval for Tacrolimus Ointment's clinic trial.  Full Article

North China Pharmaceutical unit gets WHO PQ authentication
Tuesday, 28 Jun 2016 01:25am EDT 

North China Pharmaceutical Co Ltd <600812.SS> :Says its unit gets WHO PQ(Confirmation of WHO Active Pharmaceutical Ingredient Pre-qualification) authentication for its streptomycin sulfate.  Full Article

North China Pharmaceutical to pay 2015 dividend on June 21
Wednesday, 15 Jun 2016 04:10am EDT 

North China Pharmaceutical Co., Ltd. <600812.SS> : Says it will pay cash dividend of 0.02 yuan per share (before tax) for 2015 to shareholders of A shares of record on June 20 .Says the company's shares will be traded ex-right and ex-dividend on June 21 and the dividend will be paid on June 21.  Full Article

More From Around the Web

BRIEF-North China Pharmaceutical receives GMP certificate

* Says it received goods manufacture practice(GMP) certificate from Hebei Food and Drug Administration on March 21